GSF: Gilead Research Scholars - Liver Disease- Primary Biliary Cholangitis US Grant

GSF: Gilead Research Scholars - Liver Disease- Primary Biliary Cholangitis US Grant

Status: ACTIVE
Funder: Gilead Sciences Foundation
Amount: Up to US $180,000
Last Updated: November 27, 2025

Summary

The Gilead Research Scholars Program focuses on innovative research in areas of unmet medical need, including Primary Biliary Cholangitis (PBC). Designed for early-stage investigators, it offers up to $180,000 in funding over two years to support projects addressing health inequities. The program prioritizes applicants from underrepresented groups and fosters diversity to enhance scientific progress. Successful candidates must demonstrate a commitment to research and have a mentor experienced in PBC.

Overview

Gilead Research Scholars Our Focus is Innovation The Research Scholars Program supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuit of scientific understanding and progress. We believe that new, diverse voices and research topics are needed to advance scientific knowledge in areas of unmet medical need and create a healthier world. Program Overview Since its launch in 2008, the Research Scholars Program has supported meaningful research by high-caliber emerging investigators to help transform scientific understanding, address knowledge gaps and drive medical breakthroughs in the following therapeutic areas: OncologyVirologyLiver Disease The Research Scholars Program awards provide two years of financial support to junior faculty researchers. Each award is funded depending on country and region, paid as two annual installments directly to the scholar’s institution. Funding for the second year is contingent upon submission of a progress report and approval by the chair of the program’s scientific review committee. Diversity Fosters Innovation The Research Scholars Program is actively working towards reducing potential barriers to entry and success for applicants from population groups who are typically underrepresented in research. Award selections are made without discrimination based on race, ethnicity, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression. We are committed to supporting researchers and research projects addressing unmet patient needs and health inequities in order to build a more inclusive research landscape. Liver Disease - Primary Biliary Cholangitis This award is intended for junior faculty who meet the criteria for Early Stage Investigator, as defined by the National Institutes of Health (NIH). Note, those who have received substantial NIH research awards, such as being a PI on an R01, P01, or U01, are not Early Stage Investigators, according to NIH criteria. Please be aware that some entities have their own restrictions against acceptance of the RSP Award, for example the NIH Loan Repayment Program. Please check before preparing your application. Funding The program provides financial support to the institutions of 2 early career researchers for a 2-year period.  Each award is funded up to $180,000 USD (inclusive of any indirect costs), to be paid in annual installments of up to $90,000 USD per year for 2 years. Funding for the second year is contingent upon submission of a progress report by each early career researcher and approval by the chair of the Scientific Review Committee, who oversees the program.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Prior research experience in PBC is not necessary as long as the applicant meets the requirements below:Hold an MD or PhD, or equivalent degree at time of application submissionHave received your initial faculty appointment within the last 7 years in association with a research institution in the United States at the time of applicationHave a strong career interest in Primary Biliary Cholangitis and HepatologyHave a research mentor with experience in the field of Primary Biliary Cholangitis (co-mentorship is accepted)Be able to devote at least 30% of professional time to research for the next two years (versus administrative, patient care, or teaching responsibilities)Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the researchExceptions to the above can apply, for example, having taken time out for parental leave or family bereavement.An applicant must be a citizen or permanent resident of the United States or subject to the qualifications noted below hold a temporary non-immigrant visa/work permit. This visa must be valid and must allow the applicant to undertake the research over the 2-year award period from the United States. This non-immigrant visa/work permit must be valid for the 2-year award period or applicant must be able to establish that he or she is eligible for an extension, renewal or other status that will enable the applicant to perform the research in the applicable jurisdiction for the entirety of the 2-year award period.Most post-fellowship positions are considered faculty positions. This could include, but is not limited to the following: Instructor, Assistant Professor, Associate Professor, Assistant Researcher, Lecturer, and Assistant Project Scientist. Institutions differ with regard to what they consider to be faculty positions. Please check with your institution as to what is a faculty appointment.Successful candidates will normally hold a faculty position in an appropriate university or research institute.

Ineligibility

Research investigating Gilead product(s) are not eligible for funding through the Research Scholars Program.Interventional clinical studies or trials involving patient administration of any pharmaceutical drugs.Co-principal investigators are not eligible for funding.Applicants with certain NIH awards at the time of application - R01, P01, U01. Also those on the NIH Loan Repayment Program. It's permissible if these are granted during the award period (if you are applying for these at the same time as the RSP award). Duplicative funding: the RSP award cannot overlap with other current or pending funding. It can be used to support a larger research project, as long as it supports a specific component of it.Applicants on visas shorter than the 2-year award period who cannot provide evidence for the duration of the term for the contract.